US-based merchant bank Burrill & Company has made a second closing of its latest healthcare fund at $505m after corporations joined. The fundraising followed the $2.6bn raised by venture capital firm New Enterprise Associates earlier this year, with more than $700m targeted for life sciences. Although corporations are known to have joined Burrill’s fund as…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
